| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |